Advertisement
Screener

Standard BioTools Inc. (LAB) Income Taxes Paid

1.7 / 5 stars · 27/80 Roast Me

Standard BioTools Inc. Income Taxes Paid

Standard BioTools Inc. (LAB) reported Income Taxes Paid of -$9.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:IncomeTaxesPaidNet · last filed 2026-08-05

  • Standard BioTools Inc. income taxes paid, net for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
  • Standard BioTools Inc. income taxes paid, net for the quarter ending 2026-03-31 was -$9.00K.
  • Standard BioTools Inc. income taxes paid, net for the quarter ending 2025-12-31 was -$21.00K, a 110.50% decline year-over-year.
  • Standard BioTools Inc. income taxes paid, net for the quarter ending 2025-09-30 was -$72.00K, a 220.00% decline year-over-year.
  • Standard BioTools Inc. income taxes paid, net for fiscal 2025 was -$73.00K, a 112.03% decline from fiscal 2024.
  • Standard BioTools Inc. income taxes paid, net for fiscal 2024 was $607.00K, a 24.22% decline from fiscal 2023.
  • Standard BioTools Inc. income taxes paid, net for fiscal 2023 was $801.00K, a 159.22% increase from fiscal 2022.
  • Standard BioTools Inc. income taxes paid, net for fiscal 2022 was $309.00K, a 85.18% decline from fiscal 2021.
Period endIncome Taxes Paid, Net 3 monthIncome Taxes Paid, Net 3 month as first filedIncome Taxes Paid, Net 6 monthIncome Taxes Paid, Net 9 monthIncome Taxes Paid, Net 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$9.00K
10-Q · filed 2026-08-05
-$30.00K
derived: sum of 3 quarters · filed 2026-08-05
-$102.00K
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$9.00K
10-Q · filed 2026-05-06
-$30.00K
derived: sum of 2 quarters · filed 2026-05-06
-$102.00K
derived: sum of 3 quarters · filed 2026-05-06
$119.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$21.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
-$93.00K
derived: sum of 2 quarters · filed 2026-03-16
$128.00K
derived: sum of 3 quarters · filed 2026-08-05
-$73.00K
10-K · filed 2026-03-16
2025-09-30-$72.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$149.00K
derived: sum of 2 quarters · filed 2026-08-05
-$52.00K
10-Q · filed 2025-11-04
$148.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$221.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$20.00K
10-Q · filed 2026-08-05
$220.00K
derived: sum of 3 quarters · filed 2026-08-05
$280.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$201.00K
10-Q · filed 2026-05-06
$201.00K
10-Q · filed 2025-05-06
-$1.00K
derived: sum of 2 quarters · filed 2026-05-06
$59.00K
derived: sum of 3 quarters · filed 2026-05-06
$166.00K
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$200.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$260.00K
derived: sum of 2 quarters · filed 2026-03-16
$367.00K
derived: sum of 3 quarters · filed 2026-03-16
$607.00K
10-K · filed 2026-03-16
2024-09-30$60.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$167.00K
derived: sum of 2 quarters · filed 2025-11-04
$407.00K
10-Q · filed 2025-11-04
$579.00K
derived: sum of 4 quarters · filed 2026-03-16
2024-06-30$107.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15
$347.00K
10-Q · filed 2025-08-15
$519.00K
derived: sum of 3 quarters · filed 2026-03-16
$636.00K
derived: sum of 4 quarters · filed 2026-03-16
2024-03-31$240.00K
10-Q · filed 2025-05-06
$412.00K
derived: sum of 2 quarters · filed 2026-03-16
$529.00K
derived: sum of 3 quarters · filed 2026-03-16
$735.00K
derived: sum of 4 quarters · filed 2026-03-16
2023-12-31$172.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$289.00K
derived: sum of 2 quarters · filed 2026-03-16
$495.00K
derived: sum of 3 quarters · filed 2026-03-16
$801.00K
10-K · filed 2026-03-16
2023-09-30$117.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$323.00K
derived: sum of 2 quarters · filed 2024-11-06
$629.00K
10-Q · filed 2024-11-06
$690.00K
derived: sum of 4 quarters · filed 2025-03-11
2023-06-30$206.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$512.00K
10-Q · filed 2024-08-06
$573.00K
derived: sum of 3 quarters · filed 2025-03-11
$183.00K
derived: sum of 4 quarters · filed 2025-03-11
2023-03-31$306.00K
10-Q · filed 2024-05-09
$367.00K
derived: sum of 2 quarters · filed 2025-03-11
-$23.00K
derived: sum of 3 quarters · filed 2025-03-11
$127.00K
derived: sum of 4 quarters · filed 2025-03-11
2022-12-31$61.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
-$329.00K
derived: sum of 2 quarters · filed 2025-03-11
-$179.00K
derived: sum of 3 quarters · filed 2025-03-11
$309.00K
10-K · filed 2025-03-11
2022-09-30-$390.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$240.00K
derived: sum of 2 quarters · filed 2023-11-07
$248.00K
10-Q · filed 2023-11-07
$1.22M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30$150.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$638.00K
10-Q · filed 2023-08-08
$1.61M
derived: sum of 3 quarters · filed 2023-08-08
$1.30M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$488.00K
10-Q · filed 2023-05-09
$1.46M
derived: sum of 2 quarters · filed 2023-05-09
$1.16M
derived: sum of 3 quarters · filed 2023-05-09
$1.37M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$972.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14
$667.00K
derived: sum of 2 quarters · filed 2023-03-14
$885.00K
derived: sum of 3 quarters · filed 2023-03-14
$2.08M
10-K · filed 2023-03-14
2021-09-30-$305.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$87.00K
derived: sum of 2 quarters · filed 2022-11-09
$1.11M
10-Q · filed 2022-11-09
$1.25M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$218.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$1.42M
10-Q · filed 2022-08-09
$1.55M
derived: sum of 3 quarters · filed 2022-08-09
$1.75M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$1.20M
10-Q · filed 2022-05-09
$1.33M
derived: sum of 2 quarters · filed 2022-05-09
$1.53M
derived: sum of 3 quarters · filed 2022-05-09
$1.63M
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31$135.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$327.00K
derived: sum of 2 quarters · filed 2022-03-08
$434.00K
derived: sum of 3 quarters · filed 2022-03-08
$521.00K
10-K · filed 2022-03-08
2020-09-30$192.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$299.00K
derived: sum of 2 quarters · filed 2021-11-09
$386.00K
10-Q · filed 2021-11-09
$463.00K
derived: sum of 4 quarters · filed 2022-03-08
2020-06-30$107.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$194.00K
10-Q · filed 2021-08-06
$271.00K
derived: sum of 3 quarters · filed 2022-03-08
$260.00K
derived: sum of 4 quarters · filed 2022-03-08
2020-03-31$87.00K
10-Q · filed 2021-05-07
$164.00K
derived: sum of 2 quarters · filed 2022-03-08
$153.00K
derived: sum of 3 quarters · filed 2022-03-08
$263.00K
derived: sum of 4 quarters · filed 2022-03-08
2019-12-31$77.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$66.00K
derived: sum of 2 quarters · filed 2022-03-08
$176.00K
derived: sum of 3 quarters · filed 2022-03-08
$205.00K
10-K · filed 2022-03-08
2019-09-30-$11.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$99.00K
derived: sum of 2 quarters · filed 2020-11-09
$128.00K
10-Q · filed 2020-11-09
2019-06-30$110.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$139.00K
10-Q · filed 2020-08-07
2019-03-31$29.00K
10-Q · filed 2020-05-11
2018-12-31$321.00K
10-K · filed 2021-02-25
2017-12-31$245.00K
10-K · filed 2020-02-27
2016-12-31$355.00K
10-K · filed 2019-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01